Immutep
IMMP
3 hedge funds and large institutions have $76K invested in Immutep in 2019 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 4 closing their positions.
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
0.02% less ownership
Funds ownership: 0.02% → 0% (-0.02%)
50% less funds holding
Funds holding: 6 → 3 (-3)
75% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 4
93% less capital invested
Capital invested by funds: $1.02M → $76K (-$945K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$27.9K |
| 2 |
TRCT
Tower Research Capital (TRC)
New York
|
+$266 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PC
Polar Capital
London,
United Kingdom
|
-$835K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$120K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$10K |
| 4 |
Morgan Stanley
New York
|
-$1.53K |
| 5 |
Wells Fargo
San Francisco,
California
|
-$1K |
IMMP Hedge Fund Activity: Q3 2019 in Review
3 of the 4,560 institutional investors tracked by Wall St. Rank reported a position in Immutep (IMMP) for Q3 2019, worth a combined $76K — down 93% from $1.02M a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of IMMP and 1 opened new positions — a net loss of 3 holders — while 1 trimmed existing stakes and 1 added.
The largest buyer was Renaissance Technologies, adding an estimated $27.9K. The largest seller was Polar Capital, exiting entirely with an estimated $835K sold.
- 3 institutional investors held Immutep (IMMP) as of Q3 2019, down from 6 in Q2 2019.
- Funds reported $76K of Immutep stock for Q3 2019, down 93% quarter-over-quarter.
- 1 fund opened new Immutep positions in Q3 2019 and 4 closed out, a net change of -3 holders.
- The largest Immutep buyer in Q3 2019 was Renaissance Technologies, an estimated $27.9K added.
- The largest Immutep seller in Q3 2019 was Polar Capital, an estimated $835K sold.
Based on aggregated 13F filings for Q3 2019.